PUBLISHER: Fortune Business Insights Pvt. Ltd. | PRODUCT CODE: 1930021
PUBLISHER: Fortune Business Insights Pvt. Ltd. | PRODUCT CODE: 1930021
Albumin Market Size, Share, Growth and Global Industry Analysis By Type & Application, Regional Insights and Forecast to 2025-2034
Growth Factors of albumin Market
The global albumin market demonstrated strong momentum in 2025, with the market valued at USD 7.23 billion. Albumin, a vital plasma protein synthesized by the liver, plays a crucial role in maintaining oncotic pressure, transporting hormones and nutrients, and supporting critical therapeutic applications. The market is projected to expand to USD 7.70 billion in 2026 and further reach USD 13.33 billion by 2034, reflecting consistent expansion during the forecast period. In 2025, North America held a leading position with a 21.71% market share, supported by robust therapeutic demand, advanced plasma collection infrastructure, and strong pharmaceutical investment activity.
Albumin products are extensively used in hypoalbuminemia treatment, drug delivery systems, wound care, liver disorders, and critical care settings. Rising hospitalization rates, increasing prevalence of chronic liver diseases, cardiac surgeries, and infectious conditions have significantly elevated clinical demand. Continuous research activity and expanding therapeutic indications are reinforcing the long-term growth outlook of the albumin market.
Market Drivers and Growth Factors
One of the primary drivers of albumin market growth is the increasing prevalence of hypoalbuminemia and liver-related disorders. Conditions such as sepsis, cirrhosis, renal disorders, and cardiovascular surgeries frequently result in reduced albumin synthesis, necessitating albumin-based therapies. According to liver disease prevalence data cited in the report, a substantial patient population in the U.S. alone requires albumin infusion as part of standard critical care protocols.
Additionally, the aging global population continues to contribute to rising disease burden, especially among elderly patients who are more susceptible to albumin deficiency. Growth of the biopharmaceutical industry is another major catalyst, as albumin is increasingly used as a stabilizing agent and carrier protein in biologics, immunotherapy, and monoclonal antibody development. Rising healthcare expenditure and expanding clinical research activities further support market expansion.
Market Restraints and Regulatory Challenges
Despite favorable demand dynamics, the albumin market faces constraints related to stringent regulatory frameworks governing plasma collection, processing, and commercialization. In regions such as the U.S. and Canada, albumin production is regulated under strict blood safety laws, requiring compliance with quality, donor safety, and traceability standards. Lengthy approval timelines and limited availability of compliant plasma sources increase operational complexity and may restrict rapid market penetration in certain countries.
Emerging Opportunities and Market Trends
Significant market opportunities are emerging from increased R&D investments in recombinant albumin products. Recombinant albumin offers advantages such as high purity, reduced contamination risk, and suitability for drug delivery and advanced therapies. The report highlights growing interest in blood-free recombinant formulations, which enhance patient safety and enable scalable production.
Strategic collaborations and partnerships among leading manufacturers are accelerating innovation. Companies such as Grifols S.A., CSL Behring, and Takeda Pharmaceutical Company Limited are actively expanding their albumin portfolios through clinical trials, geographic expansion, and regulatory approvals. Increased adoption of albumin in drug delivery systems and personalized medicine remains a key trend shaping future demand.
Segmentation Insights
By product type, human serum albumin dominated the market, accounting for 89.66% share in 2026, driven by government approvals and high clinical adoption. Recombinant albumin continues to gain traction due to its application in biologics and advanced therapies, while bovine serum albumin maintains steady demand in research applications.
From an application perspective, the therapeutics segment led the market, holding 65.17% share in 2026, supported by increasing prescriptions in hospitals and critical care units. Diagnostics and research applications also exhibited steady growth due to rising chronic disease screening and expanding laboratory infrastructure.
Regional Outlook
The Asia Pacific albumin market generated USD 4.01 billion in 2025, rising to USD 4.33 billion in 2026, making it the largest regional market. Growth is supported by expanding private hospital infrastructure and increased adoption of plasma-derived therapies in China, Japan, and India. North America followed with a market size of USD 1.66 billion in 2026, driven by high therapeutic usage and strong R&D activity. Europe reached USD 1.08 billion in 2026, supported by plasma fractionation expansion and regulatory advancements.
Competitive Landscape
The competitive landscape is characterized by product launches, facility expansions, and strategic partnerships. Key players continue to strengthen their global presence through innovation and regulatory approvals, ensuring sustained market competitiveness across regions.
Report Coverage
The global albumin market report delivers a comprehensive assessment of the industry landscape for the period 2025 to 2034, with 2025 as the base year and 2026 and 2034 as key reference years for market sizing and forecasting. The report provides in-depth insights into market size and value trends, growth dynamics, and competitive positioning across major regions.
The study covers detailed analysis by product type, application, and end user, highlighting the performance of human serum albumin, recombinant albumin, and bovine serum albumin across therapeutic, diagnostic, and research applications. Regional coverage includes North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa, with country-level insights for key markets such as the United States, China, Japan, Germany, and the United Kingdom.
In addition, the report evaluates market drivers, restraints, opportunities, challenges, and emerging trends, along with the impact of regulatory frameworks and technological advancements. The competitive landscape section profiles major industry participants and examines strategic developments such as partnerships, product launches, capacity expansions, and regulatory approvals that are shaping the global albumin market.
Conclusion
The global albumin market showed solid performance in 2025, with a market value of USD 7.23 billion, reflecting strong demand from therapeutic and biopharmaceutical applications. Continued expansion to USD 7.70 billion in 2026 and further growth to USD 13.33 billion by 2034 indicate sustained adoption of albumin-based products across clinical and research settings.
Growth momentum is supported by the rising prevalence of hypoalbuminemia, liver disorders, and critical care conditions, along with increasing use of albumin in biologics and drug delivery systems. While regulatory complexities and high production costs pose challenges, ongoing investments in recombinant technologies, plasma infrastructure expansion, and strategic collaborations are strengthening market fundamentals.
Regional growth remains led by Asia Pacific, followed by North America and Europe, driven by expanding healthcare infrastructure, rising plasma-derived therapy adoption, and strong R&D activity. Overall, the albumin market is positioned for steady long-term expansion, supported by clinical necessity, technological innovation, and increasing integration into advanced therapeutic applications.
Segmentation By Product
- Human Serum Albumin
- Recombinant Albumin
- Bovine Serum Albumin
By Application
- Therapeutics
- Diagnostics
- Research
By End-user
- Hospital & Clinics
- Pharmaceutical & Biotechnology Industry
- Research Institutes
By Region
- North America (By Product, Application, End-user, and Country)
- U.S.
- Canada
- Europe (By Product, Application, End-user, and Country/Sub-region)
- U.K.
- Germany
- France
- Italy
- Spain
- Scandinavia
- Rest of Europe
- Asia Pacific (By Product, Application, End-user, and Country/Sub-region)
- China
- Japan
- India
- Australia
- Southeast Asia
- Rest of Asia Pacific
- Latin America (By Product, Application, End-user, and Country/Sub-region)
- Brazil
- Mexico
- Rest of Latin America
- Middle East & Africa (By Product, Application, End-user, and Country/Sub-region)
- GCC
- South Africa
- Rest of the Middle East & Africa
Table of Content
1. Introduction
- 1.1. Research Scope
- 1.2. Market Segmentation
- 1.3. Research Methodology
- 1.4. Definitions and Assumptions
2. Executive Summary
3. Market Dynamics
- 3.1. Market Drivers
- 3.2. Market Restraints
- 3.3. Market Opportunities
- 3.4. Market Trends
4. Key Insights
- 4.1. Prevalence of Key Disorders: by Key Countries/Sub-regions, 2024/2025
- 4.2. Overview: rHSA Product Parameters
- 4.3. New Product Launches, By Key Players
- 4.4. Pipeline Analysis, By Key Players
- 4.5. Key Industry Developments (Mergers, Acquisitions and Partnerships)
- 4.6. Impact of COVID-19 on the Market
5. Global Albumin Market Analysis, Insights and Forecast, 2021-2034
- 5.1. Market Analysis, Insights and Forecast - By Product
- 5.1.1. Human Serum Albumin
- 5.1.2. Recombinant Albumin
- 5.1.3. Bovine Serum Albumin
- 5.2. Market Analysis, Insights and Forecast - By Application
- 5.2.1. Therapeutics
- 5.2.2. Diagnostics
- 5.2.3. Research
- 5.3. Market Analysis, Insights and Forecast - By End-user
- 5.3.1. Hospital & Clinics
- 5.3.2. Pharmaceutical & Biotechnology Industry
- 5.3.3. Research Institutes
- 5.4. Market Analysis, Insights and Forecast - By Region
- 5.4.1. North America
- 5.4.2. Europe
- 5.4.3. Asia Pacific
- 5.4.4. Latin America
- 5.4.5. Middle East & Africa
6. North America Albumin Market Analysis, Insights and Forecast, 2021-2034
- 6.1. Market Analysis, Insights and Forecast - By Product
- 6.1.1. Human Serum Albumin
- 6.1.2. Recombinant Albumin
- 6.1.3. Bovine Serum Albumin
- 6.2. Market Analysis, Insights and Forecast - By Application
- 6.2.1. Therapeutics
- 6.2.2. Diagnostics
- 6.2.3. Research
- 6.3. Market Analysis, Insights and Forecast - By End-user
- 6.3.1. Hospital & Clinics
- 6.3.2. Pharmaceutical & Biotechnology Industry
- 6.3.3. Research Institutes
- 6.4. Market Analysis - By Country
- 6.4.1. U.S.
- 6.4.2. Canada
7. Europe Albumin Market Analysis, Insights and Forecast, 2021-2034
- 7.1. Market Analysis, Insights and Forecast - By Product
- 7.1.1. Human Serum Albumin
- 7.1.2. Recombinant Albumin
- 7.1.3. Bovine Serum Albumin
- 7.2. Market Analysis, Insights and Forecast - By Application
- 7.2.1. Therapeutics
- 7.2.2. Diagnostics
- 7.2.3. Research
- 7.3. Market Analysis, Insights and Forecast - By End-user
- 7.3.1. Hospital & Clinics
- 7.3.2. Pharmaceutical & Biotechnology Industry
- 7.3.3. Research Institutes
- 7.4. Market Analysis, Insights and Forecast- By Country/ Sub-Region
- 7.4.1. U.K.
- 7.4.2. Germany
- 7.4.3. France
- 7.4.4. Spain
- 7.4.5. Italy
- 7.4.6. Scandinavia
- 7.4.7. Rest of Europe
8. Asia Pacific Albumin Market Analysis, Insights and Forecast, 2021-2034
- 8.1. Market Analysis, Insights and Forecast - By Product
- 8.1.1. Human Serum Albumin
- 8.1.2. Recombinant Albumin
- 8.1.3. Bovine Serum Albumin
- 8.2. Market Analysis, Insights and Forecast - By Application
- 8.2.1. Therapeutics
- 8.2.2. Diagnostics
- 8.2.3. Research
- 8.3. Market Analysis, Insights and Forecast - By End-user
- 8.3.1. Hospital & Clinics
- 8.3.2. Pharmaceutical & Biotechnology Industry
- 8.3.3. Research Institutes
- 8.4. Market Analysis, Insights and Forecast - By Country/ Sub-Region
- 8.4.1. Japan
- 8.4.2. China
- 8.4.3. India
- 8.4.4. Australia
- 8.4.5. Southeast Asia
- 8.4.6. Rest of Asia Pacific
9. Latin America Albumin Market Analysis, Insights and Forecast, 2021-2034
- 9.1. Market Analysis, Insights and Forecast - By Product
- 9.1.1. Human Serum Albumin
- 9.1.2. Recombinant Albumin
- 9.1.3. Bovine Serum Albumin
- 9.2. Market Analysis, Insights and Forecast - By Application
- 9.2.1. Therapeutics
- 9.2.2. Diagnostics
- 9.2.3. Research
- 9.3. Market Analysis, Insights and Forecast - By End-user
- 9.3.1. Hospital & Clinics
- 9.3.2. Pharmaceutical & Biotechnology Industry
- 9.3.3. Research Institutes
- 9.4. Market Analysis, Insights and Forecast - By Country/ Sub-Region
- 9.4.1. Brazil
- 9.4.2. Mexico
- 9.4.3. Rest of Latin America
10. Middle East & Africa Albumin Market Analysis, Insights and Forecast, 2021-2034
- 10.1. Market Analysis, Insights and Forecast - By Product
- 10.1.1. Human Serum Albumin
- 10.1.2. Recombinant Albumin
- 10.1.3. Bovine Serum Albumin
- 10.2. Market Analysis, Insights and Forecast - By Application
- 10.2.1. Therapeutics
- 10.2.2. Diagnostics
- 10.2.3. Research
- 10.3. Market Analysis, Insights and Forecast - By End-user
- 10.3.1. Hospital & Clinics
- 10.3.2. Pharmaceutical & Biotechnology Industry
- 10.3.3. Research Institutes
- 10.4. Market Analysis, Insights and Forecast - By Country/ Sub-Region
- 10.4.1. GCC Countries
- 10.4.2. South Africa
- 10.4.3. Rest of Middle East & Africa
11. Competitive Analysis
- 11.1. Global Market Share Analysis (2025)
- 11.2. Company Profiles
- 11.2.1. CSL Behring (CSL)
- 11.2.1.1. Overview
- 11.2.1.2. Products
- 11.2.1.3. SWOT Analysis
- 11.2.1.4. Recent Developments
- 11.2.1.5. Strategies
- 11.2.1.6. Financials (Based on Availability)
- 11.2.2. Kedrion S.p.A.
- 11.2.2.1. Overview
- 11.2.2.2. Products
- 11.2.2.3. SWOT Analysis
- 11.2.2.4. Recent Developments
- 11.2.2.5. Strategies
- 11.2.2.6. Financials (Based on Availability)
- 11.2.3. Takeda Pharmaceutical Company Limited
- 11.2.3.1. Overview
- 11.2.3.2. Products
- 11.2.3.3. SWOT Analysis
- 11.2.3.4. Recent Developments
- 11.2.3.5. Strategies
- 11.2.3.6. Financials (Based on Availability)
- 11.2.4. Lazuline Bio
- 11.2.4.1. Overview
- 11.2.4.2. Products
- 11.2.4.3. SWOT Analysis
- 11.2.4.4. Recent Developments
- 11.2.4.5. Strategies
- 11.2.4.6. Financials (Based on Availability)
- 11.2.5. InVitria
- 11.2.5.1. Overview
- 11.2.5.2. Products
- 11.2.5.3. SWOT Analysis
- 11.2.5.4. Recent Developments
- 11.2.5.5. Strategies
- 11.2.5.6. Financials (Based on Availability)
- 11.2.6. Biorbyt Ltd.
- 11.2.6.1. Overview
- 11.2.6.2. Products
- 11.2.6.3. SWOT Analysis
- 11.2.6.4. Recent Developments
- 11.2.6.5. Strategies
- 11.2.6.6. Financials (Based on Availability)
- 11.2.7. Grifols, S.A.
- 11.2.7.1. Overview
- 11.2.7.2. Products
- 11.2.7.3. SWOT Analysis
- 11.2.7.4. Recent Developments
- 11.2.7.5. Strategies
- 11.2.7.6. Financials (Based on Availability)
- 11.2.8. Octapharma AG
- 11.2.8.1. Overview
- 11.2.8.2. Products
- 11.2.8.3. SWOT Analysis
- 11.2.8.4. Recent Developments
- 11.2.8.5. Strategies
- 11.2.8.6. Financials (Based on Availability)
- 11.2.9. Albumin Bioscience
- 11.2.9.1. Overview
- 11.2.9.2. Products
- 11.2.9.3. SWOT Analysis
- 11.2.9.4. Recent Developments
- 11.2.9.5. Strategies
- 11.2.9.6. Financials (Based on Availability)
- 11.2.10. Aspira Chemical
- 11.2.10.1. Overview
- 11.2.10.2. Products
- 11.2.10.3. SWOT Analysis
- 11.2.10.4. Recent Developments
- 11.2.10.5. Strategies
- 11.2.10.6. Financials (Based on Availability)
- 11.2.11. ALBUMEDIX (Sartorius AG)
- 11.2.11.1. Overview
- 11.2.11.2. Products
- 11.2.11.3. SWOT Analysis
- 11.2.11.4. Recent Developments
- 11.2.11.5. Strategies
- 11.2.11.6. Financials (Based on Availability)
- 11.2.12. Cyagen Biosciences
- 11.2.12.1. Overview
- 11.2.12.2. Products
- 11.2.12.3. SWOT Analysis
- 11.2.12.4. Recent Developments
- 11.2.12.5. Strategies
- 11.2.12.6. Financials (Based on Availability)
- 11.2.13. Merck KGaA
- 11.2.13.1. Overview
- 11.2.13.2. Products
- 11.2.13.3. SWOT Analysis
- 11.2.13.4. Recent Developments
- 11.2.13.5. Strategies
- 11.2.13.6. Financials (Based on Availability)
- 11.2.14. Thermo Fisher Scientific Inc.
- 11.2.14.1. Overview
- 11.2.14.2. Products
- 11.2.14.3. SWOT Analysis
- 11.2.14.4. Recent Developments
- 11.2.14.5. Strategies
- 11.2.14.6. Financials (Based on Availability)
- 11.2.1. CSL Behring (CSL)
List of Tables
- Table 1: Global Albumin Market Revenue (USD billion) Forecast, by Product, 2021-2034
- Table 2: Global Albumin Market Revenue (USD billion) Forecast, by Application, 2021-2034
- Table 3: Global Albumin Market Revenue (USD billion) Forecast, by End-user, 2021-2034
- Table 4: Global Albumin Market Revenue (USD billion) Forecast, by Region, 2021-2034
- Table 5: North America Albumin Market Revenue (USD billion) Forecast, by Product, 2021-2034
- Table 6: North America Albumin Market Revenue (USD billion) Forecast, by Application, 2021-2034
- Table 7: North America Albumin Market Revenue (USD billion) Forecast, by End-user, 2021-2034
- Table 8: North America Albumin Market Revenue (USD billion) Forecast, By Country, 2021-2034
- Table 9: Europe Albumin Market Revenue (USD billion) Forecast, by Product, 2021-2034
- Table 10: Europe Albumin Market Revenue (USD billion) Forecast, by Application, 2021-2034
- Table 11: Europe Albumin Market Revenue (USD billion) Forecast, by End-user, 2021-2034
- Table 12: Europe Albumin Market Revenue (USD billion) Forecast, By Country/ Sub-region, 2021-2034
- Table 13: Asia Pacific Albumin Market Revenue (USD billion) Forecast, by Product, 2021-2034
- Table 14: Asia Pacific Albumin Market Revenue (USD billion) Forecast, by Application, 2021-2034
- Table 15: Asia Pacific Albumin Market Revenue (USD billion) Forecast, by End-user, 2021-2034
- Table 16: Asia Pacific Albumin Market Revenue (USD billion) Forecast, By Country/ Sub-region, 2021-2034
- Table 17: Latin America Albumin Market Revenue (USD billion) Forecast, by Product, 2021-2034
- Table 18: Latin America Albumin Market Revenue (USD billion) Forecast, by Application, 2021-2034
- Table 19: Latin America Albumin Market Revenue (USD billion) Forecast, by End-user, 2021-2034
- Table 20: Latin America Albumin Market Revenue (USD billion) Forecast, By Country/ Sub-region, 2021-2034
- Table 21: Middle East & Africa Albumin Market Revenue (USD billion) Forecast, by Product, 2021-2034
- Table 22: Middle East & Africa Albumin Market Revenue (USD billion) Forecast, by Application, 2021-2034
- Table 23: Middle East & Africa Albumin Market Revenue (USD billion) Forecast, by End-user, 2021-2034
- Table 24: Middle East & Africa Albumin Market Revenue (USD billion) Forecast, By Country/ Sub-region, 2021-2034
List of Figures
- Figure 1: Global Albumin Market Revenue Breakdown (USD Billion, %) by Region, 2025 & 2034
- Figure 2: Global Albumin Market Value Share (%), by Product, 2025 & 2034
- Figure 3: Global Albumin Market Value Share (%), by Application, 2025 & 2034
- Figure 4: Global Albumin Market Value Share (%), by End-user, 2025 & 2034
- Figure 5: Global Albumin Market Value (USD billion), by Region, 2025 & 2034
- Figure 6: North America Albumin Market Value (USD billion), by Product, 2025 & 2034
- Figure 7: North America Albumin Market Value Share (%), by Product, 2025
- Figure 8: North America Albumin Market Value (USD billion), by Application, 2025 & 2034
- Figure 9: North America Albumin Market Value Share (%), by Application, 2025
- Figure 10: North America Albumin Market Value (USD billion), by End-user, 2025 & 2034
- Figure 11: North America Albumin Market Value Share (%), by End-user, 2025
- Figure 12: North America Albumin Market Value (USD billion), By Country, 2025 & 2034
- Figure 13: North America Albumin Market Value Share (%), By Country, 2025
- Figure 14: Europe Albumin Market Value (USD billion), by Product, 2025 & 2034
- Figure 15: Europe Albumin Market Value Share (%), by Product, 2025
- Figure 16: Europe Albumin Market Value (USD billion), by Application, 2025 & 2034
- Figure 17: Europe Albumin Market Value Share (%), by Application, 2025
- Figure 18: Europe Albumin Market Value (USD billion), by End-user, 2025 & 2034
- Figure 19: Europe Albumin Market Value Share (%), by End-user, 2025
- Figure 20: Europe Albumin Market Value (USD billion), By Country/ Sub-region, 2025 & 2034
- Figure 21: Europe Albumin Market Value Share (%), By Country/ Sub-region, 2025
- Figure 22: Asia Pacific Albumin Market Value (USD billion), by Product, 2025 & 2034
- Figure 23: Asia Pacific Albumin Market Value Share (%), by Product, 2025
- Figure 24: Asia Pacific Albumin Market Value (USD billion), by Application, 2025 & 2034
- Figure 25: Asia Pacific Albumin Market Value Share (%), by Application, 2025
- Figure 26: Asia Pacific Albumin Market Value (USD billion), by End-user, 2025 & 2034
- Figure 27: Asia Pacific Albumin Market Value Share (%), by End-user, 2025
- Figure 28: Asia Pacific Albumin Market Value (USD billion), By Country/ Sub-region, 2025 & 2034
- Figure 29: Asia Pacific Albumin Market Value Share (%), By Country/ Sub-region, 2025
- Figure 30: Latin America Albumin Market Value (USD billion), by Product, 2025 & 2034
- Figure 31: Latin America Albumin Market Value Share (%), by Product, 2025
- Figure 32: Latin America Albumin Market Value (USD billion), by Application, 2025 & 2034
- Figure 33: Latin America Albumin Market Value Share (%), by Application, 2025
- Figure 34: Latin America Albumin Market Value (USD billion), by End-user, 2025 & 2034
- Figure 35: Latin America Albumin Market Value Share (%), by End-user, 2025
- Figure 36: Latin America Albumin Market Value (USD billion), By Country/ Sub-region, 2025 & 2034
- Figure 37: Latin America Albumin Market Value Share (%), By Country/ Sub-region, 2025
- Figure 38: Middle East & Africa Albumin Market Value (USD billion), by Product, 2025 & 2034
- Figure 39: Middle East & Africa Albumin Market Value Share (%), by Product, 2025
- Figure 40: Middle East & Africa Albumin Market Value (USD billion), by Application, 2025 & 2034
- Figure 41: Middle East & Africa Albumin Market Value Share (%), by Application, 2025
- Figure 42: Middle East & Africa Albumin Market Value (USD billion), by End-user, 2025 & 2034
- Figure 43: Middle East & Africa Albumin Market Value Share (%), by End-user, 2025
- Figure 44: Middle East & Africa Albumin Market Value (USD billion), By Country/ Sub-region, 2025 & 2034
- Figure 45: Middle East & Africa Albumin Market Value Share (%), By Country/ Sub-region, 2025
- Figure 46: Global Albumin Market Share (%), By Company, 2025
